ASX:MVPPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals
MEDICAL DEVELOPMENTS INTERNATNL ORD
$0.470
+$0.015 (+3.30%)
Day Range
$0.450 - $0.470
52 Week Range
$0.365 - $0.765
Volume
52.44K
Avg Volume (10D)
214.56K
Market Cap
$52.95M
P/E Ratio
541.67
Price Chart
Market Statistics
Open$0.465
Previous Close$0.455
Day High$0.470
Day Low$0.450
52 Week High$0.765
52 Week Low$0.365
Valuation
Market Cap52.95M
Shares Outstanding112.66M
P/E Ratio (Annual)541.67
Price to Book0.94
Trading Activity
Volume52.44K
Value Traded24.06K
Bid$0.450 × 13,548
Ask$0.470 × 51,999
Performance
1 Day-4.21%
5 Day-5.21%
13 Week0.00%
52 Week-28.91%
YTD-18.02%
Technical Indicators
RSI (14)57.67
50-Day SMA$0.416
200-Day SMA$0.546
Latest News
Biotechnology
Medical Developments International Achieves Positive Cash Flow in Strong Q3 Performance
Medical Developments International posts strong Q3 FY26: revenue $10.5m up 19%, positive cash flow and progress on European paediatric Penthrox approvals.
1 min read
Biotechnology
Medical Developments strikes deal with Daiichi Sankyo to export Penthrox green whistle to China
Medical solutions company Medical Developments International (ASX: MVP) has set out intentions to expand its market presence by signing an exclusive distribution and license agreement with Tokyo-listed Daiichi Sankyo for its Penthrox drug in China, Thailand and Vietnam. According to the terms of the deal, Daiichi Sankyo will pay Medical Developments as much as US$32.5 […]
4 min read
